| Reference | Species | Genes Addressed |
|---|
Abdolrasouli A, et al. (2025) Cluster of clonal fluconazole-resistant Candida parapsilosis harbouring Y132F mutation in ERG11 gene in a neonatal ICU in the UK. J Antimicrob Chemother CGD Papers Entry Pubmed Entry | C. parapsilosis | |ERG11 |
Amann V, et al. (2025) Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options. Pharmaceuticals (Basel) 18(4) CGD Papers Entry Pubmed Entry | C. albicans | |FCA1 |FCY2 |
Anaele EN, et al. (2025) Trends in Prevalence of Yeast Species Associated With Urogenital Infection in Nsukka, Nigeria: An Overview of True Candida Species and Genotyping of Candida albicans hwp1-Heterozygous Isolates. Int J Microbiol 2025:3115363 CGD Papers Entry Pubmed Entry | C. albicans | |HWP1 |ITS1 |ITS2 |
Chavez JF, et al. (2025) Virulence Factors and Molecular Identification of Candida Species Causing Candidemia in Honduras. J Fungi (Basel) 11(7) CGD Papers Entry Pubmed Entry | C. albicans | |ITS1 |ITS2 |
Dishan A, et al. (2025) Candida species covered from traditional cheeses: Characterization of C. albicans regarding virulence factors, biofilm formation, caseinase activity, antifungal resistance and phylogeny. Food Microbiol 127:104679 CGD Papers Entry Pubmed Entry | C. albicans | |ERG11 |GSC1 |GSL1 |HSP90 |PLB1 |
Ejaz H, et al. (2025) Investigation of multi-drug resistant Candida auris using species-specific molecular markers in immunocompromised patients from a tertiary care hospital in Quetta, Pakistan. PLoS One 20(4):e0319485 CGD Papers Entry Pubmed Entry | C. auris | |ITS1 |ITS2 |
El Hady R, et al. (2025) Phenotypic and genotypic characterization of Candida parapsilosis complex isolates from a Lebanese hospital. Sci Rep 15(1):4853 CGD Papers Entry Pubmed Entry | C. parapsilosis | |ALS6 |ALS7 |CDR1 |ERG11 |ERG6 |SAP7 |SAP9 |SAPP3 |UPC2 |
El-Dawy EGAM, et al. (2025) Characterization and virulence of yeasts associated with neonatal thrush. BMC Microbiol 25(1):366 CGD Papers Entry Pubmed Entry | C. glabrata | |PLB1 |
| C. parapsilosis | |CPAR2_209720 |
| C. albicans | |PLB1 |SAP1 |
| C. dubliniensis | |Cd36_62110 |Cd36_63430 |
ElFeky DS, et al. (2025) Comparative evaluation of antifungal susceptibility testing methods of invasive Candida species and detection of FKS genes mutations in caspofungin intermediate and resistant isolates. BMC Infect Dis 25(1):114 CGD Papers Entry Pubmed Entry | C. glabrata | |FKS1 |FKS2 |
| C. parapsilosis | |FKS1 |FKS2 |
Faraji R, et al. (2025) Evaluation of epidemiological, clinical, and microbiological features of vulvovaginal candidiasis. GMS Hyg Infect Control 20:Doc15 CGD Papers Entry Pubmed Entry |
Franconi I, et al. (2025) The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis. JAC Antimicrob Resist 7(3):dlaf051 CGD Papers Entry Pubmed Entry | C. parapsilosis | |MRR1 |
Gao L, et al. (2025) In vitro and in vivo activity of 1,2,3,4,6-O-pentagalloyl-glucose against Candida albicans. Antimicrob Agents Chemother :e0177524 CGD Papers Entry Pubmed Entry | C. albicans | |ENO1 |
Jia H, et al. (2025) Discovery of novel azole derivatives with benzanilide-containing hydrophobic side chains for the treatment of drug-resistant fungal infections. RSC Adv 15(13):10170-10182 CGD Papers Entry Pubmed Entry | C. albicans | |CDR1 |ERG11 |
Korem M, et al. (2025) Inter-Institutional Dynamics and Impact of Fluconazole-Resistant Candida parapsilosis. Mycoses 68(1):e70017 CGD Papers Entry Pubmed Entry | C. parapsilosis | |ERG11 |
Levi O, et al. (2025) Genome-wide CRISPRi screen and proteomic profiling identify key genes related to ferulic acid's antifungal activity. mBio :e0190925 CGD Papers Entry Pubmed Entry | C. albicans | |ERG11 |TAC1 |
Lim SJ, et al. (2025) Elucidating the Virulence Roles of Secreted Aspartyl Proteinase (Sap1972) in Non-albicans Meyerozyma guilliermondii through Construction of a Structure-guided Mutant. Microb Pathog :107937 CGD Papers Entry Pubmed Entry |
Ling Z, et al. (2025) Gut mycobiota dysbiosis and systemic immune dysfunction in Chinese schizophrenia patients with metabolic syndrome. Front Immunol 16:1652633 CGD Papers Entry Pubmed Entry | C. albicans | |ITS1 |
Martins NRC, et al. (2025) Antifungal profile of menadione tethered to 1H-1,2,3-triazolyl-selenoester: synthesis, in vitro and in silico analyses. Bioorg Med Chem 130:118380 CGD Papers Entry Pubmed Entry | C. glabrata | |ERG11 |HSC82 |
Meral Ocal M, et al. (2025) Myricetin Exerts Antibiofilm Effects on Candida albicans by Targeting the RAS1/cAMP/EFG1 Pathway and Disruption of the Hyphal Network. J Fungi (Basel) 11(5) CGD Papers Entry Pubmed Entry | C. albicans | |ALS3 |CYR1 |ECE1 |EFG1 |HGC1 |HWP1 |RAS1 |UME6 |
Morales-Lopez S, et al. (2025) HWP1 Gene Sequence Diversity and Antifungal Susceptibility Patterns in Colombian Vulvovaginal Isolates of the Candida albicans Species Complex. Int J Microbiol 2025:8507361 CGD Papers Entry Pubmed Entry | C. parapsilosis | |HWP1 |
| C. dubliniensis | |HWP1 |
| C. albicans | |HWP1 |
Moustafa SMN, et al. (2025) Synthesis and Evaluating the Anticandidal Activities of Triazino[4,3-a]Quinolinecarboxylate Derivatives: A Promising Approach to Combat Candida Infections. Chem Biodivers :e202500045 CGD Papers Entry Pubmed Entry | C. glabrata | |ERG11 |
| C. albicans | |ERG11 |
Murillo MI, et al. (2025) Evaluation of the Antifungal Properties of Azomethine-Pyrazole Derivatives from a Structural Perspective. ChemistryOpen :e202500132 CGD Papers Entry Pubmed Entry | C. albicans | |ERG11 |
Namvar Z, et al. (2025) Expression of SAP1-3 genes in non-albicans Candida isolates in bovine raw milk and human sample. Folia Microbiol (Praha) CGD Papers Entry Pubmed Entry |
Okamoto M, et al. (2025) CRISPR-Cas9 RNP-Mediated Deletion of ERG25 in Non-albicans Candida Species, Including Candida auris. Med Mycol J 66(2):35-43 CGD Papers Entry Pubmed Entry | C. auris | |ERG25 |
| C. parapsilosis | |ERG25 |
| C. glabrata | |ERG25 |
Palladini G, et al. (2025) Inter-Hospital Spread of Fluconazole-Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production. Mycoses 68(9):e70111 CGD Papers Entry Pubmed Entry | C. parapsilosis | |ERG11 |ITS1 |ITS2 |
Reitler P, et al. (2025) A screen to identify antifungal antagonists reveals a variety of pharmacotherapies that induce echinocandin tolerance in Candida albicans. Antimicrob Agents Chemother :e0048425 CGD Papers Entry Pubmed Entry | C. albicans | |BCK1 |C1_05370C_A |C6_02190C_A |CEK1 |CHK1 |CKA1 |CKA2 |CKB1 |CKB2 |CR_06040W_A |EFG1 |FRK1 |HOG1 |HSL1 |MORE |
Sharma V, et al. (2025) Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary-Care Hospital in North India. Mycoses 68(5):e70062 CGD Papers Entry Pubmed Entry | C. parapsilosis | |CDR1 |ERG11 |MDR1 |
Suwannaphong P, et al. (2025) Fluconazole tolerance and virulence adaptations of Candida albicans isolated from head and neck cancer patients. J Oral Microbiol 17(1):2559024 CGD Papers Entry Pubmed Entry | C. albicans | |ALS1 |ALS3 |CDR1 |CDR2 |ERG11 |HWP1 |MDR1 |SAP6 |
Vahedi-Shahandashti R, et al. (2025) Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? Antimicrob Agents Chemother :e0024125 CGD Papers Entry Pubmed Entry | C. parapsilosis | |FKS1 |
Williams CC and Usher J (2025) Leveraging synthetic genetic array screening to identify therapeutic targets and inhibitors for combatting azole resistance in Candida glabrata. Microbiol Spectr :e0252224 CGD Papers Entry Pubmed Entry | C. glabrata | |CAGL0F04257g |GCN5 |PDR1 |STE12 |STE2 |